Full Body Radiographs for Skeletal Structure Analysis
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to study how the human skeleton changes with age using a new low-dose x-ray system called EOS imaging. By analyzing full-body x-ray images every ten years, researchers hope to understand normal skeletal changes over time. The trial seeks participants without a history of spine surgery or serious joint issues, who have been healthy without major surgeries or conditions affecting bones or joints. As an unphased study, this trial offers participants a unique opportunity to contribute to groundbreaking research on aging and bone health.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the EOS imaging system is safe for skeletal structure analysis?
Research has shown that EOS imaging is a safe and well-tolerated method for capturing full-body images. Studies have found that it uses a low amount of radiation, enhancing safety. This makes it safer than traditional x-rays, particularly for full-body scans.
EOS imaging also assists in assessing leg length and planning knee and hip surgeries, demonstrating its reliability in medical settings. No major side effects have been reported in studies using this imaging system.
Overall, evidence suggests that EOS imaging is a safe choice for obtaining detailed bone images.12345Why are researchers excited about this trial?
Unlike traditional X-rays or CT scans used for skeletal analysis, EOS imaging offers a full-body, low-dose radiographic option that can capture detailed 2D and 3D images. This technology allows for precise analysis of spino-pelvic parameters with significantly less radiation exposure, making it safer for repeated use, especially in younger patients. Researchers are excited about EOS imaging because it provides more comprehensive data on skeletal alignment and posture, which could lead to better diagnostic insights and treatment planning for conditions like scoliosis and other musculoskeletal disorders.
What evidence suggests that the EOS imaging system is effective for skeletal structure analysis?
Research has shown that EOS imaging, which participants in this trial will undergo, reliably examines bones. It provides clear, full-body images with significantly less radiation than regular X-rays. Studies have found that EOS can accurately measure key angles and positions of the spine and pelvis, aiding in understanding bone alignment and posture. Additionally, EOS offers image quality comparable to standard X-rays, making it a safe and effective method for studying changes in bones over time.16789
Who Is on the Research Team?
Christopher Kleck, MD
Principal Investigator
University of Colorado, Denver
Are You a Good Fit for This Trial?
This trial is for men and women aged 21-85 with no history of spine surgery. It's not suitable for those who've had knee replacements, severe joint arthritis, spinal trauma or surgery, certain disability scores, inflammatory disorders, significant past fractures or surgeries on the pelvis or lower limbs, are pregnant, have a history of cancer or a BMI over 37.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Imaging
Participants undergo a single EOS biplanar x-ray imaging session to analyze whole body skeletal structure
Follow-up
Participants' radiographic data is analyzed for age-related changes in skeletal structure
What Are the Treatments Tested in This Trial?
Interventions
- EOS imaging
EOS imaging is already approved in European Union, United States, Canada for the following indications:
- Orthopedic assessments
- Scoliosis monitoring
- Musculoskeletal disorders
- Orthopedic assessments
- Scoliosis monitoring
- Musculoskeletal disorders
- Hip and knee replacement surgeries
- Orthopedic assessments
- Scoliosis monitoring
- Musculoskeletal disorders
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Colorado, Denver
Lead Sponsor